Results 141 to 150 of about 3,528,989 (183)

Cutaneous Neuroendocrine Metastases of Visceral Origin Responsive to Surgical Resection and Targeted Radionuclide Therapy. [PDF]

Case Rep Dermatol Med
Tung-Hahn E, El-Haddad G, Strosberg J.
europepmc   +1 more source

Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence. [PDF]

Eur J Nucl Med Mol Imaging
Dieudonné A, Bailly C, Cachin F, Edet-Sanson A, Kraeber-Bodéré F, Hapdey S, Merlin C, Robin P, Salaun PY, Schwartz P, Tonnelet D, Vera P, Courbon F, Carlier T.   +13 more
europepmc   +1 more source

Targeted radionuclide therapy against GARP expressing T regulatory cells after tumour priming with external beam radiotherapy in a murine syngeneic model. [PDF]

Heliyon
Bellaye PS, Dias AM, Vrigneaud JM, Bouchard A, Moreau M, Petitot C, Bernhard C, Claron M, Froidurot L, Morgand V, Guillemin M, Monterrat M, Mirjolet C, Garrido C, Kohli E, Collin B.   +15 more
europepmc   +1 more source

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands. [PDF]

Pharmaceuticals (Basel)
de Roode KE, Joosten L, Behe M.
europepmc   +1 more source

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response. [PDF]

Front Immunol
Yang Y, Vedvyas Y, Alcaina Y, Son JY, Min IM, Jin MM.   +5 more
europepmc   +1 more source

Autophagy inhibition improves the targeted radionuclide therapy efficacy of ¹³¹I-FAP-2286 in pancreatic cancer xenografts. [PDF]

J Transl Med
Liu X, Li D, Ma T, Luo X, Peng Y, Wang T, Zuo C, Cai J.   +7 more
europepmc   +1 more source

Targeted Radionuclide Therapy [PDF]

Cancers, 2011
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the
Devrim Erşahin
exaly   +3 more sources

Peptide-Targeted Radionuclide Therapy for Melanoma [PDF]

Critical Reviews in Oncology/Hematology, 2008
Melanocortin-1 receptor (MC1-R) and melanin are two attractive melanoma-specific targets for peptide-targeted radionuclide therapy for melanoma. Radiolabeled peptides targeting MC1-R/melanin can selectively and specifically target cytotoxic radiation generated from therapeutic radionuclides to melanoma cells for cell killing, while sparing the normal ...
Thomas P Quinn, Yubin Miao
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Targeted Radionuclide Therapy of Melanoma

Seminars in Nuclear Medicine, 2016
An estimated 60,000 individuals in the United States and 132,000 worldwide are yearly diagnosed with melanoma. Until recently, treatment options for patients with stages III-IV metastatic disease were limited and offered marginal, if any, improvement in overall survival. The situation changed with the introduction of B-RAF inhibitors and anti-cytotoxic
Abdullah, Norain, Ekaterina, Dadachova
openaire   +2 more sources